Curis Lifesciences Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Curis Lifesciences Ltd is ₹ 124.9 as of 30 Apr 15:30 . The P/E Ratio of Curis Lifesciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 34.3 on March 2021 to 57.3 on March 2025 . This represents a CAGR of 10.81% over 5 years The Market Cap of Curis Lifesciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 43002 crore on March 2021 to ₹ 109468 crore on March 2025 . This represents a CAGR of 20.55% over 5 years The revenue of Curis Lifesciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Torrent Pharmaceuticals Ltd for the Dec '25 is ₹ 3290 crore as compare to the Sep '25 revenue of ₹ 3275 crore. This represent the growth of 0.46% The ebitda of Curis Lifesciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Torrent Pharmaceuticals Ltd for the Dec '25 is ₹ 1065 crore as compare to the Sep '25 ebitda of ₹ 1043 crore. This represent the growth of 2.11% The net profit of Curis Lifesciences Ltd changed from ₹ 1.2 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 457 crore to ₹ 635 crore over 7 quarters. This represents a CAGR of 20.68% The Dividend Payout of Curis Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 52.06 % on March 2021 to 10.76 % on March 2025 . This represents a CAGR of -27.04% over 5 years .

About Curis Lifesciences Ltd

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010.
Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar. Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic.

About Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

FAQs for the comparison of Curis Lifesciences Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Curis Lifesciences Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Curis Lifesciences Ltd is 100 Cr while Market cap of Torrent Pharmaceuticals Ltd is 141,859 Cr

What are the key factors driving the stock performance of Curis Lifesciences Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Curis Lifesciences Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Curis Lifesciences Ltd and Torrent Pharmaceuticals Ltd?

As of May 4, 2026, the Curis Lifesciences Ltd stock price is INR ₹124.9. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹4191.5.

How do dividend payouts of Curis Lifesciences Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Curis Lifesciences Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.